View More View Less
  • 1 Onkoradiológiai Központ, Fővárosi Önkormányzat Uzsoki utcai Kórháza, 1145, Budapest, Uzsoki u. 29–41.
  • | 2 Onkológiai Gondozó, Bajcsy Zsilinszky Kórház-Rendelőintézet, Budapest
Restricted access

Absztrakt

Napjainkra egyre inkább az idős emberek teszik ki az onkológiai betegek többségét. Mivel a véletlen besorolásos klinikai vizsgálatok beválasztási kritériumai többnyire kizárják a 60–65 évnél idősebbeket, nagyon kevés bizonyított adatunk van a kemoterápia és/vagy a célzott biológiai terápia valódi értékéről ebben a korosztályban. A szisztémás gyógyszeres kezelések ugyanolyan eredménnyel kecsegtetnek az idős betegeknél, mint a fiataloknál, de az időseknél a kísérőbetegségek korlátozhatják a várható élettartamot és a kezelés hatásosságát is. Az onkológus és a geriátriai szakorvos közötti szoros együttműködés szükséges az idős rákbeteg kezelésének eldöntéséhez.

  • 1. S Ananda KM Field S Kosmider et al.2008 Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice J Clin Oncol 26 4516 4517.

    • Search Google Scholar
    • Export Citation
  • 2. L Balducci M Extermann 2000 Management of cancer in the older person: A practical approach Oncologist 5 224 237.

  • 3. S Barni M Cabbidu F Petrelli 2008 Toxicity of targeted therapies in elderly patients Expert Rev Anticancer Ther 8 1965 1976.

  • 4. Barrueco J , Marschall J, Michell E, et al. Safety and efficacy of the first-line irinotecan/fluoropyrimidine combinations in mCRC patients >65 years compared with those ≤65. The BICC-C study. Proc ASCO 25 (Suppl 18): 182s, Abstr 4076, 2007.

    • Search Google Scholar
    • Export Citation
  • 5. R Bollina G Beretta D Toniolo et al.2003 Capecitabine© and irinotecan (I)(CAPIRI): A good combination in elderly patients (pts) with advanced colorectal cancer (ACRC) as first-line chemotherapy (CT). Preliminary results of a phase II trial Proc ASCO 22 1332.

    • Search Google Scholar
    • Export Citation
  • 6. Bouchahda M , Maraculla T, Spano JP. Cetuximab and irinotecan-based chemotherapy as an active and safe treatment option for elderly patients with extensively pre-treated metastatic colorectal cancer. Proc ASCO 25(Suppl 18):627s, Abstr 14528, 2007.

    • Search Google Scholar
    • Export Citation
  • 7. I Chau AR Norman D Cunningham et al.2004 Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy Br J Cancer 91 1453 1458.

    • Search Google Scholar
    • Export Citation
  • 8. P Comella D Natale A Farris et al.2005 Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: Final results of the Southern Italy Cooperative Oncology Group Trial 0108 Cancer 104 282 289.

    • Search Google Scholar
    • Export Citation
  • 9. A De Gramont A Figer M Seymour et al.2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947.

    • Search Google Scholar
    • Export Citation
  • 10. J Feliú P Escudero F Losa et al.2004 A Phase II sudy of capecitabine (X) in elderly patients (p) as 1st line treatment for patients (pts) with advanced or metastatic colorectal cancer (MCRC) Proc ASCO 22 3567.

    • Search Google Scholar
    • Export Citation
  • 11. J Feliú A Salud P Escudero et al.2006 XELOX (capecitabine plus oxaliplatin) as first-line treatment of elderly patients over 70 years of age with advanced colorectal cancer Br J Cancer 94 969 975.

    • Search Google Scholar
    • Export Citation
  • 12. Feliú J , Salut A, Safont M, et al. First-line bevacizumab plus capecitabine for elderly patients with metastatic colorectal cancer: BECA trial. J Clin Oncol 26 (Suppl): Abstr 15120, 2008.

    • Search Google Scholar
    • Export Citation
  • 13. K Field S Kosmider M Jefford et al.2008 Chemotherapy dosing strategies in the obese, elderly, and thin patient: Results of a nationwide survey J Oncol Pract 4 108 113.

    • Search Google Scholar
    • Export Citation
  • 14. G Folprecht D Cunningham P Ross et al.2004 Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: A pooled analysis of clinical trials Ann Oncol 15 1330 1338.

    • Search Google Scholar
    • Export Citation
  • 15. G Folprecht MT Seymour L Saltz et al.2008 Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials J Clin Oncol 26 1443 1451.

    • Search Google Scholar
    • Export Citation
  • 16. S Gill CL Loprinzi DJ Sargent et al.2004 Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 22 1797 1806.

    • Search Google Scholar
    • Export Citation
  • 17. RM Goldberg I Tabah-Fisch H Bleiberg et al.2006 Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer J Clin Oncol 24 4085 4091.

    • Search Google Scholar
    • Export Citation
  • 18. RM Goldberg 2005 Advances in the treatment of metastatic colorectal cancer The Oncologist 10(Suppl 3) 40 48.

  • 19. Gravalos C , Rivers F, Massuti B, et al. Cetuximab and capecitabine as first-line treatment for elderly patients (pts) with metastatic colorectal cancer (mCRC): preliminary results of TTD trial. J Clin Oncol 26 (Suppl): Abstr 15027, 2008.

    • Search Google Scholar
    • Export Citation
  • 20. DG Haller PJ Catalano JS Macdonald et al.2005 Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage ii and iii colon cancer: final report of Intergroup 0089 J Clin Oncol 23 8670 8678.

    • Search Google Scholar
    • Export Citation
  • 21. Ho C , O'Reilly S, Ng K, et al. Population-based analysis of patients with advanced colorectal cancer: The impact of age on treatment and outcomes. J Clin Oncol 23: 274s, Abstr 3614, 2005.

    • Search Google Scholar
    • Export Citation
  • 22. HS Hochster W Luo EC Popa et al.2007 Phase II study of uracil-tegafur with leucovorin in elderly (≥75 years old) patients with colorectal cancer: ECOG 1299 J Clin Oncol 25 5397 5402.

    • Search Google Scholar
    • Export Citation
  • 23. H Hurwitz L Fehrenbacher W Novotny et al.2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342.

    • Search Google Scholar
    • Export Citation
  • 24. TJ Iwashyna EB Lamont 2002 Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer J Clin Oncol 20 3992 3998.

    • Search Google Scholar
    • Export Citation
  • 25. SA Jensen JT Lønborg JB Sorensen 2006 Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experience Acta Oncol 45 67 76.

    • Search Google Scholar
    • Export Citation
  • 26. JM Jessup A Stewart FL Greene et al.2005 Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentation JAMA 294 2703 2711.

    • Search Google Scholar
    • Export Citation
  • 27. FF Kabbinavar J Schultz M McCleod et al.2005 Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial J Clin Oncol 23 3697 3705.

    • Search Google Scholar
    • Export Citation
  • 28. NL Keating MB Landrum CN Klabunde et al.2008 Adjuvant chemotherapy for stage III colon cancer: Do physicians agree about the importance of patients age and comorbidity? J Clin Oncol 26 2532 2537.

    • Search Google Scholar
    • Export Citation
  • 29. H Kelly RM Goldberg 2005 Systemic therapy for metastatic colorectal cancer: Current options, current evidence J Clin Oncol 23 4553 4560.

    • Search Google Scholar
    • Export Citation
  • 30. Kozloff MF , Sugrue MM, Purdie DM, et al. Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer: results from the BRiTE observational cohort study. J Clin Oncol 26 (Suppl): Abstr 4026, 2008.

    • Search Google Scholar
    • Export Citation
  • 31. C-H Köhne G Folprecht RM Goldberg et al.2008 Chemotherapy in elderly patients with colorectal cancer Oncologist 13 390 402.

  • 32. F Levi R Zidani C Focan et al.2002 Age-independent benefit of chronotherapy with 5-fluorouracil, leucovorin, and oxaliplatin in patients with metastatic colorectal cancer within multicenter randomized Phase III trials Proc ASCO 21 1431.

    • Search Google Scholar
    • Export Citation
  • 33. SM Lichtman MK Boparai 2008 Anticancer drug therapy in the older cancer patients: pharmacology and polypharmacy Curr Treat Options Oncol 9 191 203.

    • Search Google Scholar
    • Export Citation
  • 34. SM Lichtman H Eildiers E Chatelut et al.2007 International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of chemotherapy in older patients – an analysis of the medical literature J Clin Oncol 25 1832 1843.

    • Search Google Scholar
    • Export Citation
  • 35. E Mitry C Tournigand T André et al.2004 Comparison of the tolerance and efficacy of LV5FU2-CPT11 and FOLFIRI regimens in front-line treatment of advanced colorectal cancer – a pooled analysis of 254 patients included in 2 randomized trials Proc ASCO 22 3576.

    • Search Google Scholar
    • Export Citation
  • 36. HB Muss L Biganzoli DJ Sargent M Aapro 2007 Adjuvant therapy in the elderly: Making the right decision J Clin Oncol 25 1870 1875.

  • 37. AL Potosky LC Harlan RS Kaplan et al.2002 Age, sex, and racial difference in the use of standard adjuvant therapy for colorectal cancer J Clin Oncol 20 1192 1202.

    • Search Google Scholar
    • Export Citation
  • 38. Puthillath AA , Mashtare T, Wilding G, et al. A Phase II study of first-line biweekly regimen of capecitabine (CAP) and bevacizumab (BV) in elderly patients with metastatic colorectal cancer. Gastrointestinal Cancer Symposium, Orlando FL, USA, 2527 January 2008, Abstr 511.

    • Search Google Scholar
    • Export Citation
  • 39. Raman AK , Lombardo JC, Chandrasekhar R, et al. Bevacizumab (BV) related adverse events among various age groups of elderly patients with advanced colorectal cancer. Proc ASCO 25 (18 Suppl): Abstr 14546, 2007.

    • Search Google Scholar
    • Export Citation
  • 40. G Rosati S Cordio A Tucci et al.2005 Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients Oncology 69 122 129.

    • Search Google Scholar
    • Export Citation
  • 41. P Rougier E Mitry D Cunningham et al.2003 Is age a prognostic factor of toxicity and efficacy in patients (pts) with metastatic colorectal cancer (MCRC) receiving irinotecan in combination with 5FU/folinic acid (FA) Proc ASCO 22 1072.

    • Search Google Scholar
    • Export Citation
  • 42. LB Saltz JV Cox C Blanke et al.2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 905 914.

    • Search Google Scholar
    • Export Citation
  • 43. HK Sanoff H Bleiberg RM Goldberg 2007 Managing older patients with colorectal cancer J Clin Oncol 25 1891 1897.

  • 44. DJ Sargent RM Goldberg SD Jacobson et al.2001 A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients N Engl J Med 345 1091 1097.

    • Search Google Scholar
    • Export Citation
  • 45. Sargent J , Wieand HS, Benedetti J, et al. Disease-free survival vs overall survival as a primary endpoint for adjuvant colon cancer studies: individual patient data from 12,915 patients on 15 randomized trials. J Clin Oncol 22 (Suppl): 246a, Abstr 3502, 2004.

    • Search Google Scholar
    • Export Citation
  • 46. J Sastre E Marcuello B Masutti et al.2005 Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors study J Clin Oncol 23 3545 3551.

    • Search Google Scholar
    • Export Citation
  • 47. M Saunders T Iveson 2006 Management of advanced colorectal cancer: State of the art Br J Cancer 95 131 138.

  • 48. FA Scappaticci JR Skillings N Holden et al.2007 Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J Natl Cancer Inst 99 1232 1239.

    • Search Google Scholar
    • Export Citation
  • 49. D Schrag LD Cramer PB Bach et al.2001 Age and adjuvant chemotherapy use after surgery for stage III colon cancer J Natl Cancer Inst 93 850 857.

    • Search Google Scholar
    • Export Citation
  • 50. MT Seymour TS Maughan HS Wasan et al.2007 Capecitabine (Cap) and oxaliplatin (Ox) in elderly and/or frail patients with metastatic colorectal cancer: The FOCUS2 trial Proc ASCO 25 9030.

    • Search Google Scholar
    • Export Citation
  • 51. JR Skillings DH Johnson F Miller et al.2005 Arterial thromboembolic events (ATEs) in a pooled analysis of 5 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy Proc ASCO 23 3019.

    • Search Google Scholar
    • Export Citation
  • 52. J Souglakos A Pallis S Kakolyris et al.2005 Combination of irinotecan (CPT11) plus 5-flourouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: A phase II trial Oncology 69 384 390.

    • Search Google Scholar
    • Export Citation
  • 53. Sugrue MM , Kozloff H, Hainsworth J, et al. Safety and effectiveness of bevacizumab plus chemotherapy in elderly patients with mCRC: Results from the BRiTE registry. Gastrointestinal Cancer Symposium, Orlando, FL, USA, 1921 January 2007, Abstr 345.

    • Search Google Scholar
    • Export Citation
  • 54. Sugrue MM , Yi J, Purdie DM, et al. Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV): results from the BRiTE registry. Proc ASCO 25 (18 Suppl): Abstr 4136, 2007.

    • Search Google Scholar
    • Export Citation
  • 55. V Sundararajan N Mitra JS Jacobson et al.2002 Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer Ann Intern Med 136 349 357.

    • Search Google Scholar
    • Export Citation
  • 56. I Tabah-Fisch F Maindrault-Goebel M Benavides et al.2002 Oxaliplatin/5FU/LV is feasible, safe, and active in elderly colorectal cancer (CRC) patients Proc ASCO 21 56.

    • Search Google Scholar
    • Export Citation
  • 57. C Terret GB Zulian A Naiem et al.2007 Multidisciplinary approach to the geriatric oncology patients J Clin Oncol 25 1876 1881.

  • 58. C Tournigand T Andre E Achille et al.2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GRECOR study J Clin Oncol 22 229 237.

    • Search Google Scholar
    • Export Citation
  • 59. C Twelves CA Butts J Cassidy et al.2005 Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: Post hoc analysis of a large Phase II study Clin Colorectal Cancer 5 101 107.

    • Search Google Scholar
    • Export Citation

Magyar Onkológia
Language Hungarian
Size  
Year of
Foundation
1956
Publication
Programme
 
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Onkológusok Társasága
Founder's
Address
H-1122 Budapest, Hungary Ráth György u. 7-9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0025-0244 (Print)
ISSN 2060-0399 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 2 0 0
May 2021 3 0 0
Jun 2021 7 0 0
Jul 2021 5 0 0
Aug 2021 16 0 0
Sep 2021 8 0 0
Oct 2021 0 0 0